We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...

We came across a bullish thesis on Sana Biotechnology, Inc. (SANA) on wallstreetbets Subreddit Page by Intrepid_Web5454. In ...

Last week, Sana Biotechnology, a once-mysterious and still-buzzy biotech startup, released clinical trial results showing that it had managed to implant insulin-producing cells in the arm muscle ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey! This is Meghana. Hope ...

Analyst Vikram Purohit from Morgan Stanley maintained a Buy rating on Sana Biotechnology (SANA – Research Report) and keeping the price target ...

Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells ...

Sana Biotechnology has a 1 year low of $1.52 and a 1 year high of $12.00. Sana Biotechnology ( NASDAQ:SANA – Get Free Report ) last issued its quarterly earnings results on Friday, November 8th.

https://www.tipranks.com/news/the-fly/fortress-biotech-announces-first-patient-dosed-in-phase-2-trial-of-triplex BofA lowered the firm’s price target on Sana ...

About the Sana Biotechnology Hypoimmune (HIP) Platform Sana’s HIP platform is designed to generate cells ex vivo that can evade the patient’s immune system to enable the transplantation of ...